1月31日,艾伯维公布了2024年业绩,全年总营收563.34亿美元,较去年有所增长(+3.7%)。研发投入为127.91亿美元,同比增长66.7%。2024年,艾伯维自免、肿瘤、美容、神经科学以及眼科各大业务分别营收266.82亿美元(+2.1%)、65.55亿美元(+10.8%)、51.76亿美元(-2.2%)、89.99亿美元(+16.6%)、22.42亿美元(-7.2%)。其中,除美容和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.